申请人:A. Menarini Industrie Farmaceutiche Riunite
公开号:US05011833A1
公开(公告)日:1991-04-30
Novel derivatives of 11-carbonyl-6,11-dihydrodibenzo[c,f][1,2,5]thiadiazepine 5,5-dioxide of the general formula ##STR1## wherein R and R.sub.1, which can be different, represent a hydrogen atom or a (C.sub.1 -C.sub.5) alkyl or (C.sub.1 -C.sub.4)hydroxyalkyl group, or R and R.sub.1 together can form a 5-membered and/or 6-membered heterocyclic ring which may contain a further heteroatom, R.sub.2 and R.sub.3, which can be different, represent a hydrogen atom, a (C.sub.1 -C.sub.3)alkoxy, (C.sub.1 -C.sub.3)alkyl, nitro, amino or (C.sub.1 -C.sub.3)alkylamino, halogen, halogeno-alkyl or hydroxyl group, R.sub.4 represents a hydrogen atom or a (C.sub.1 -C.sub.4) alkyl, alkylaryl or (C.sub.1 -C.sub.6)alkylamino group, and n assumes values of 0, 1 or 2, and non-toxic, pharmaceutically acceptable salts thereof, obtained by addition of acids or alkyl halides.
11-酮基-6,11-二氢二苯并[c,f][1,2,5]噻二唑烷-5,5-二氧化物的新衍生物,其通式为##STR1##其中R和R.sub.1,可以是不同的,代表氢原子或(C.sub.1-C.sub.5)烷基或(C.sub.1-C.sub.4)羟基烷基,或者R和R.sub.1一起可以形成一个含有进一步杂原子的5-元和/或6-元杂环,R.sub.2和R.sub.3,可以是不同的,代表氢原子,(C.sub.1-C.sub.3) 烷氧基,(C.sub.1-C.sub.3) 烷基,硝基,氨基或(C.sub.1-C.sub.3) 烷基氨基,卤素,卤代烷基或羟基,R.sub.4代表氢原子或(C.sub.1-C.sub.4) 烷基,烷基芳基或(C.sub.1-C.sub.6) 烷基氨基,n取0、1或2的值,以及通过酸或烷基卤化物的加成获得的非毒性、药学上可接受的盐。